These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 26299896)

  • 1. Optimization of Caco-2 and HT29 co-culture in vitro cell models for permeability studies.
    Pan F; Han L; Zhang Y; Yu Y; Liu J
    Int J Food Sci Nutr; 2015; 66(6):680-5. PubMed ID: 26299896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A tunable Caco-2/HT29-MTX co-culture model mimicking variable permeabilities of the human intestine obtained by an original seeding procedure.
    Béduneau A; Tempesta C; Fimbel S; Pellequer Y; Jannin V; Demarne F; Lamprecht A
    Eur J Pharm Biopharm; 2014 Jul; 87(2):290-8. PubMed ID: 24704198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining conditions for the co-culture of Caco-2 and HT29-MTX cells using Taguchi design.
    Chen XM; Elisia I; Kitts DD
    J Pharmacol Toxicol Methods; 2010; 61(3):334-42. PubMed ID: 20159047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
    Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
    J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of mucin mRNA (MUC5AC and MUC5B) expression and protein production and secretion in Caco-2/HT29-MTX co-cultures following exposure to individual and combined Fusarium mycotoxins.
    Wan LY; Allen KJ; Turner PC; El-Nezami H
    Toxicol Sci; 2014 May; 139(1):83-98. PubMed ID: 24496642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biorelevant media resistant co-culture model mimicking permeability of human intestine.
    Antoine D; Pellequer Y; Tempesta C; Lorscheidt S; Kettel B; Tamaddon L; Jannin V; Demarne F; Lamprecht A; Béduneau A
    Int J Pharm; 2015 Mar; 481(1-2):27-36. PubMed ID: 25601199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs.
    Antunes F; Andrade F; Araújo F; Ferreira D; Sarmento B
    Eur J Pharm Biopharm; 2013 Apr; 83(3):427-35. PubMed ID: 23159710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability.
    Mahler GJ; Shuler ML; Glahn RP
    J Nutr Biochem; 2009 Jul; 20(7):494-502. PubMed ID: 18715773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2/HT29-5M21).
    Nollevaux G; Devillé C; El Moualij B; Zorzi W; Deloyer P; Schneider YJ; Peulen O; Dandrifosse G
    BMC Cell Biol; 2006 May; 7():20. PubMed ID: 16670004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using 3D gastrointestinal tract in vitro models with microfold cells and mucus secreting ability to assess the hazard of copper oxide nanomaterials.
    Ude VC; Brown DM; Stone V; Johnston HJ
    J Nanobiotechnology; 2019 May; 17(1):70. PubMed ID: 31113462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards the characterization of an in vitro triple co-culture intestine cell model for permeability studies.
    Araújo F; Sarmento B
    Int J Pharm; 2013 Dec; 458(1):128-34. PubMed ID: 24120728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of Mucin (
    Huang X; Gao Y; Li S; Wu C; Wang J; Zheng N
    Toxins (Basel); 2019 Feb; 11(2):. PubMed ID: 30813459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation.
    Li N; Wang D; Sui Z; Qi X; Ji L; Wang X; Yang L
    Tissue Eng Part C Methods; 2013 Sep; 19(9):708-19. PubMed ID: 23350801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion.
    Gagnon M; Zihler Berner A; Chervet N; Chassard C; Lacroix C
    J Microbiol Methods; 2013 Sep; 94(3):274-9. PubMed ID: 23835135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles.
    Schimpel C; Teubl B; Absenger M; Meindl C; Fröhlich E; Leitinger G; Zimmer A; Roblegg E
    Mol Pharm; 2014 Mar; 11(3):808-18. PubMed ID: 24502507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of intestinal epithelial permeability and mucin mRNA (MUC2, MUC5AC, and MUC5B) expression and protein secretion in Caco-2/HT29-MTX co-cultures exposed to aflatoxin M1, ochratoxin A, and zearalenone individually or collectively.
    Wu C; Gao Y; Li S; Huang X; Bao X; Wang J; Zheng N
    Toxicol Lett; 2019 Jul; 309():1-9. PubMed ID: 30904571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of Caco-2/HT29-MTX and Caco-2/HT29-MTX/Raji B Coculture Models To Predict Intestinal and Colonic Permeability Compared to Caco-2 Monoculture.
    Lozoya-Agullo I; Araújo F; González-Álvarez I; Merino-Sanjuán M; González-Álvarez M; Bermejo M; Sarmento B
    Mol Pharm; 2017 Apr; 14(4):1264-1270. PubMed ID: 28263609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caco-2 Cell Sheet Partially Laminated with HT29-MTX Cells as a Novel In Vitro Model of Gut Epithelium Drug Permeability.
    Cheng Y; Watanabe C; Ando Y; Kitaoka S; Egawa Y; Takashima T; Matsumoto A; Murakami M
    Pharmaceutics; 2023 Sep; 15(9):. PubMed ID: 37765306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caco-2 and LS174T cell lines provide different models for studying mucin expression in colon cancer.
    Bu XD; Li N; Tian XQ; Huang PL
    Tissue Cell; 2011 Jun; 43(3):201-6. PubMed ID: 21470648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of drug permeation under fed state conditions using mucus-covered Caco-2 cell epithelium.
    Birch D; Diedrichsen RG; Christophersen PC; Mu H; Nielsen HM
    Eur J Pharm Sci; 2018 Jun; 118():144-153. PubMed ID: 29524592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.